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Cigarette Smoke and Nicotine-Induced Remodeling of Actin Cytoskeleton
and Extracellular Matrix by Vascular Smooth Muscle Cells
Chi-Ming Hai.
Brown University, Providence, RI, USA.
Cigarette smoking is a significant risk factor for atherosclerosis, which involves
the invasion of vascular smooth muscle cells (VSMCs) from the media to in-
tima. Many invasive cells remodel the actin cytoskeleton to form podosomes,
which regulate metalloproteinase (MMP) release for extracellular matrix
(ECM) degradation. We tested the hypothesis that cigarette smoke extract
(CSE) modulates the structure and function of podosomes in VSMCs. We
found that, in response to PKC activation by phorbol dibutyrate (PDBu), un-
treated A7r5 VSMCs formed podosomes, whereas CSE, nicotine, and
carbachol-treated cells formed actin-rich rings. The nicotinic acetylcholine re-
ceptor (nAChR) antagonist a-bungarotoxin abolished the effects of nicotine
and carbachol on actin-rich ring formation. Immunofluorescence labeling ex-
periments localized MMP-2 and nAChRs at the actin-rich rings. Nicotine-
induced actin-rich ring formation required 6-12 hr exposure, and was sensitive
to the protein synthesis inhibitor cycloheximide. Conditioned media collected
from cell culture of nicotine-treated cells induced podosome remodeling in un-
treated cells. When cells were cultured on DQ-gelatin, untreated cells exhibited
a fibrillar network of fluorescence from DQ-gelatin degradation, which, upon
PDBu stimulation, reorganized into peripheral dots and migrated towards the
perinuclear region. In contrast, nicotine-treated cells, upon PDBu stimulation,
reorganized the fluorescence into perinuclear fibrils, which dispersed into small
dots and disappeared rapidly over time. Results from this study suggest that nic-
otine, by activating nAChRs and inducing phenotypic modulation, may prime
VSMCs to become hyperresponsive to PKC activation with an enhanced ability
to remodel the actin cytoskeleton and release MMP for invasion of the ECM.
This study was supported by NIH grant HL-52714.
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Bupropion Binds in the Middle (M2-9) of the Torpedo Nicotinic Acetylcho-
line Receptor Ion Channel
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Bupropion is clinically prescribed for the treatment of depression (Wellbutrin)
and for smoking cessation (Zyban). While there is consensus that the primary
mechanism of action involves increased synaptic concentrations of dopamine
and norepinephrine via inhibition of the respective reuptake transporters,
DAT and NET, there is growing evidence that some of the therapeutic benefits
of bupropion may result from non-competitive antagonism of neuronal nico-
tinic acetylcholine receptors (nAChRs), in particular a4b2 and a3b4 subtypes.
To aid in elucidating the mechanism of bupropion action and the development
of new therapeutic agents for smoking cessation and depression, our goal is to
determine the specific molecular interactions between bupropion and several
nAChR subtypes (Torpedo, a4b2, a3b4). We first established that bupropion
dose-dependently and reversibly inhibits ACh-induced currents in Xenopus lae-
vis oocytes injected with affinity-purified and lipid-reconstituted Torpedo
nAChRs (IC50 0.34 mM). Using a photoreactive analog of bupropion ([
125I]-
SADU-3-72), we next established that bupropion inhibits the binding of
[125I]-SADU-3-72 to the Torpedo nAChR (IC50 closed state, 3.6 mM; desensi-
tized state, 1.2 mM) and that binding to the closed nAChR is fully inhibited by
tetracaine (IC50 0.42 mM) consistent with a bupropion/[
125I]-SADU-3-72 bind-
ing site within the nAChR channel. [125I]-SADU-3-72 photolabeled Torpedo
nAChR subunits in an agonist-sensitive and bupropion-inhibitable (specific)
manner. Finally for the closed nAChR, we identified sites of specific [125I]-
SADU-3-72 labeling within dM2 (dLeu265/dM2-9) and bM2 (bLeu257/
bM2-9). In the desensitized state, TCP-inhibitable (specific) labeling was iden-
tified within dM2 (dLeu265, dM2-9 with minor labeling of dSer258, dM2-2).
Our results establish that bupropion binds in the middle (M2-9) of the Torpedo
nAChR channel, with a slightly broader binding locus in the desensitized chan-
nel. Currently, studies are underway to identify the site(s) of [125I]-SADU-3-72
labeling in affinity-purified a4b2 and a3b4 nAChRs.
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Injection of Affinity-Purified Ligand-Gated Ion Channels into Xenopus
Laevis Oocytes for Functional Studies using Electrophysiology
Akash Pandhare, Michaela Jansen, Michael P. Blanton.
Texas Tech University Health Sciences Center, Lubbock, TX, USA.Heterologous expression after mRNA/cDNA injection into Xenopus oocytes is
a well established system for studying the structure and function of a variety of
membrane proteins including ligand-gated ion channels (LGIC). In the early
1990’s, the Miledi group [1] introduced a rather unique variant of this system
by injecting pre-assembled nicotinic acetylcholine receptors (nAChR) into oo-
cytes and measuring function using electrophysiological recordings. Native or
affinity-purified Torpedo nAChR-membranes were injected into Xenopus oo-
cytes and after incubation to allow receptor-containing membranes to fuse
with the plasma membrane, functional receptor channels were detected using
two-electrode voltage clamp recordings. Our goal is to utilize this system to as-
sess the functionality and pharmacology of affinity-purified and lipid-
reconstituted LGICs. We first determined that the optimal incubation period
for the appearance of maximal functional channels following injection of native
or affinity-purified and lipid-reconstituted Torpedo nAChRs was 48 hr. We next
established that injection of affinity-purified Torpedo nAChRs reconstituted in
lipid vesicles comprised of only phosphatidylcholine (DOPC) had minimal
functionality (300 mM i.e. >EC100 ACh-induced currents at 60 mV; ~ 13-
23 nA). In contrast, affinity-purified Torpedo nAChRs reconstituted in vesicles
comprised of DOPC/DOPA/CH (3:1:1) were fully functional (300 mM ACh at
60 mV; ~ 1-3 mA) and the EC50 for ACh (~ 50 mM) was comparable to that
obtained for Torpedo nAChR mRNA injected oocytes. These results indicate
that CH and anionic lipids (PA) are not only required for receptor functionality
[2] but are protective of receptors during detergent solubilization and affinity-
purification. Currently, studies are underway to examine the functionality of
several affinity-purified and lipid-reconstituted LGICs, including a4b2 and
a3b4 nAChRs, and 5-HT3A receptors.
[1] Marsal et al (1995) PNAS 92, 5224-5228.
[2] Hamouda et al (2006) Biochemistry 45, 4327-4337.
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Sources of Energy for Gating by Agonists in Acetylcholine Receptor-
Channels
Iva Bruhova, Prasad Purohit, Anthony Auerbach.
State University of New York at Buffalo, Buffalo, NY, USA.
The neuromuscular acetylcholine receptor (AChR) is an allosteric protein that
switches between closed- and open-channel conformations. The probability of
being open increaseswhen acetylcholine (ACh)molecules occupy the two trans-
mitter binding sites (TBS). Based on the MWC model and experimental mea-
sures of the di- and unliganded gating equilibrium constants (E2 and E0), we
estimate the energy that an agonist provides to power gating is =0.59ln(O(E2/
E0)). In wt adult neuromuscular AChRs, each ACh provides ~-5.1 kcal/mol. The
question we asked is: which TBS residues provide this energy? Using single-
channel electrophysiology, we examined four aromatic residues in thea subunit,
Y93, W149, Y190, and Y198. Mutation to Phe caused small (<1 kcal/mol) re-
ductions in energy at positions 93, 149, and 198, but a large reduction effect at
190. The removal of aromatic ring by Ala mutation caused large (>2 kcal/
mol) reductions at positions 149, 190, and 198, but not 93. These results suggest
that 149 and 198 interact with ACh mainly through the aromatic ring, not H-
bonding. Mutations of 190 to F, W, and A had the largest reductions (2.2-4.5
kcal/mol), so this residue provides most of the energy. In contrast, 93 is much
weaker as mutations to F, W, H, A, C, S, and G reduced the energy %1.1
kcal/mol. Overall, the order of energy loss was 190>>149>198>93. The
sum of the Ala mutant energy reductions for the four positions was >5.1 kcal/
mol, suggesting that these side chains interact energetically. We created double
mutant F-F constructs (n=6) and observed significant coupling (>1.5 kcal/mol)
between 190-93, 190-149, and 190-198, but little coupling between the other
pairs. Thus, 190 not only provides most of the energy for gating, but is also cou-
pled with the surrounding aromatic TBS residues. Supported by CIHR and NIH.
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choline Receptor
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Over the past three decades, the Torpedo californica nicotinic acetylcholine re-
ceptor (nAChR) has been one of the most extensively studied membrane pro-
tein systems. However, the effects of detergent solubilization on nAChR
resistance to degradation and function are poorly understood. The use of
lipid-analog detergents for nAChR solubilization has been shown to preserve
receptor integrity and functionality. The present study used lipid-analog deter-
gents from phospholipid-analog and cholesterol-analog detergent families for
solubilization and affinity purification of the receptor and probed nAChR ion
